Login to Your Account



Other News To Note


Wednesday, December 12, 2012
• Genmab A/S, of Copenhagen, Denmark, will collaborate with Kyowa Hakko Kirin Co. Ltd., of Tokyo, to develop bispecific antibodies based on Genmab's DuoBody platform.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription